Publication Date
| In 2025 | 0 |
| Since 2024 | 12 |
| Since 2021 (last 5 years) | 74 |
| Since 2016 (last 10 years) | 164 |
| Since 2006 (last 20 years) | 466 |
Descriptor
Source
Author
Publication Type
Education Level
Audience
| Teachers | 73 |
| Practitioners | 69 |
| Researchers | 18 |
| Students | 13 |
| Administrators | 7 |
| Counselors | 6 |
| Support Staff | 3 |
| Parents | 2 |
| Policymakers | 1 |
Location
| United Kingdom | 18 |
| Australia | 11 |
| United Kingdom (England) | 7 |
| Brazil | 6 |
| United States | 6 |
| Canada | 4 |
| Germany | 4 |
| Netherlands | 4 |
| California | 3 |
| China | 3 |
| District of Columbia | 3 |
| More ▼ | |
Laws, Policies, & Programs
| No Child Left Behind Act 2001 | 1 |
Assessments and Surveys
| Aberrant Behavior Checklist | 5 |
| National Council Licensure… | 2 |
| California Psychological… | 1 |
| Motivated Strategies for… | 1 |
| Obsessive Compulsive Scale | 1 |
| Vineland Adaptive Behavior… | 1 |
| Wechsler Intelligence Scale… | 1 |
What Works Clearinghouse Rating
Peer reviewedPonterotto, Joseph G. – Journal of Counseling & Development, 1985
Presents basic information on psychopharmacology and discusses the major antipsychotic, antidepressant, anti-anxiety, and lithium salt medications used with adults. The importance and implications of psychopharmacology for the counseling profession are highlighted. (Author)
Descriptors: Anxiety, Counselors, Depression (Psychology), Drug Use
Peer reviewedLewis, Mark H. – Journal of Autism and Developmental Disorders, 1996
This paper reviews recent findings on the efficacy of psychopharmacological interventions in autism, points out gaps in knowledge of the effects of specific drug classes, and suggests research directions for the future. (Author/DB)
Descriptors: Autism, Drug Therapy, Intervention, Outcomes of Treatment
Peer reviewedSeidman, Lisa A.; Warren, Noreen – American Biology Teacher, 2002
Presents a case study on the story of Dr. Frances Kelsey and the drug thalidomide, which was widely used in Europe for its therapeutic effects in the 1960s and later identified as having multiple effects on the body during development by the Food and Drug Administration (FDA). Describes the drug approval process in the United States and…
Descriptors: Congenital Impairments, Higher Education, Pharmacology, Science Education
Peer reviewedBelcastro, Philip A. – Journal of Drug Education, 1992
Reviews popular drug education textbooks and curricula. Finds most juxtapose physiologic effects of licitly manufactured drugs under headings representing illicitly prepared drugs, ignoring literature reporting that illicit drugs contain adulterants and substitutes. Concludes that one cannot extrapolate results of licitly pure drug lots…
Descriptors: Content Analysis, Drug Education, Illegal Drug Use, Pharmacology
Peer reviewedPakes, Gary E. – Journal of Technical Writing and Communication, 1993
Describes a format for writing clinical investigator's brochures for the Food and Drug Administration summarizing information about a drug that is about to enter clinical trials. (SR)
Descriptors: Higher Education, Layout (Publications), Pamphlets, Pharmacology
Peer reviewedSimonson, William; And Others – Generations, 1994
This theme issue discusses maximizing the benefits and minimizing the risks of drug therapy for older people. It includes articles on psychoactive drugs, drug-related problems, medication compliance, geriatric psychopharmacotherapy, consumer guidelines, and outpatient prescriptions drug coverage as it relates to health care reform. (JOW)
Descriptors: Aging (Individuals), Consumer Education, Drug Therapy, Geriatrics
Peer reviewedRealmuto, George M.; And Others – Journal of Autism and Developmental Disorders, 1990
Seven medication-free autistic subjects (ages 6-19) were administered clonidine and L-Dopa to investigate neuroendocrine responses through changes in growth hormone levels. Findings showed that, compared to normal controls, the L-Dopa-stimulated growth hormone peak was delayed and the clonidine growth hormone peak was premature. (Author/JDD)
Descriptors: Adolescents, Autism, Children, Drug Therapy
Peer reviewedWentland, Mark P.; Raza, Shaan; Yingtong Gao – Journal of Chemical Education, 2004
An appropriate assay to determine the inhibition potency of carboxypeptidase A (CPA) in 96-well format to illustrate how high throughput screening is used in modern drug discovery to identify bioactive molecules is developed. Efforts in developing a colorimetric 96-well plate assay for determination of the K(sub i) for inhibition of CPA by…
Descriptors: Biochemistry, Science Experiments, Science Instruction, Scientific Methodology
Direct linkCarey, John P. – Volta Review, 2005
The toxicity of certain aminoglycoside antibiotics for vestibular hair cells has been used to special advantage in the treatment of Meniere's disease. Intratympanic (middle ear) injections of these drugs are being increasingly used to control vertigo in this disorder when it has not responded to medical therapy. The mechanisms by which these drugs…
Descriptors: Drug Therapy, Diseases, Symptoms (Individual Disorders), Pharmacology
Kalinec, Federico – Volta Review, 2005
Drug ototoxicity research has relied traditionally on animal models for the discovery and development of therapeutic interventions. More than 50 years of research, however, has delivered few--if any--successful clinical strategies for preventing or ameliorating the ototoxic effects of common pharmacological drugs such as aminoglycoside…
Descriptors: Drug Therapy, Human Body, Animals, Toxicology
Weible, Aldis P.; Oh, M. Matthew; Lee, Grace; Disterhoft, John F. – Learning & Memory, 2004
Cholinergic systems are critical to the neural mechanisms mediating learning. Reduced nicotinic cholinergic receptor (nAChR) binding is a hallmark of normal aging. These reductions are markedly more severe in some dementias, such as Alzheimer's disease. Pharmacological central nervous system therapies are a means to ameliorate the cognitive…
Descriptors: Conditioning, Animals, Eye Movements, Pharmacology
Barrett, James E. – Journal of the Experimental Analysis of Behavior, 2006
Peter B. Dews played a significant role in shaping the distinctive characteristics and defining the underlying principles of the discipline of behavioral pharmacology. His early and sophisticated use of schedules of reinforcement in the 1950s, incorporated from research in the experimental analysis of behavior and integrated into the discipline of…
Descriptors: Behavior Problems, Discipline, Pharmacology, Role
Kontos, Nicholas; Querques, John; Freudenreich, Oliver – Academic Psychiatry, 2006
Objective: The psychopharmacologist designation currently pervades and heavily influences the practice, perception, and teaching of clinical psychiatry. The authors hope to make a case and provide the raw material for informed discussion of this role during psychiatric residency training. Method: A definition for the psychopharmacologist is…
Descriptors: Psychiatry, Patients, Teaching Methods, Pharmacology
Spencer, Thomas J.; Faraone, Stephen V.; Biederman, Joseph; Lerner, Marc; Cooper, Kimberly M.; Zimmerman, Brenda – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To investigate whether prolonged therapy with a long-acting stimulant affects growth in children with attention-deficit/hyperactivity disorder (ADHD). Method: One hundred seventy-eight children ages 6 to 13 years received OROS methylphenidate (OROS MPH, CONCERTA) for at least 21 months. Height and weight were measured monthly during the…
Descriptors: Body Height, Body Weight, Drug Therapy, Stimulants
McGough, James; McCracken, James; Swanson, James; Riddle, Mark; Kollins, Scott; Greenhill, Laurence; Abikoff, Howard; Davies, Mark; Chuang, Shirley; Wigal, Tim; Wigal, Sharon; Posner, Kelly; Skrobala, Anne; Kastelic, Elizabeth; Ghuman, Jaswinder; Cunningham, Charles; Shigawa, Sharon; Moyzis, Robert; Vitiello, Benedetto – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: The authors explored genetic moderators of symptom reduction and side effects in methylphenidate-treated preschool-age children diagnosed with attention-deficit/hyperactivity disorder (ADHD). Method: DNA was isolated from 81 subjects in a double-blind, placebo-controlled, crossover methylphenidate titration. Parents and teachers…
Descriptors: Hyperactivity, Genetics, Attention Deficit Disorders, Drug Therapy
